Oxford GlycoSciences plc, of Oxford, UK, appointed Denis Mulhall chief financial officer and finance director.

SinusPharma Inc., of Carpinteria, Calif., added Mike Narachi to its board. Also, its subsidiary, SinusPharmaceuticals Research Corp., added Kimberly Halaburka as general manager and vice president, product development and clinical affairs.

The Illinois Biotechnology Industry Organization in Chicago appointed James Tyree, Arthur Holden, Greg Tobin and Larry Schook to its board.

The Indiana Proteomics Consortium in Indianapolis named Brent Boekcmann vice president of business development.

Torrey Pines Institute for Molecular Studies in San Diego appointed William Beers vice president of operations.

Tripos Inc., of St. Louis, appointed Elizabeth Holbrook vice president of sales and Deepak Thakkar vice president of marketing.

Tularik Inc., of South San Francisco, appointed Edward Holmes to its board.

TurboWorx Inc., of New Haven, Conn., appointed Jeffery Augen president.

Xantos Biomedicine AG, of Martinsried, Germany, added David Chilvers as chief business officer.

XOMA Ltd., of Berkeley, Calif., appointed Michel Bergh vice president of business development; Steve Carroll vice president, scientific and product development; and Robert Gundel vice president, preclinical research.